Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOFT trial: L-OHP-based adjuvant chemotherapy followed by UFT/LV after resection of colorectal cancer liver metastases
jRCT1051190106Completed
- Start
- Feb 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of oxaliplatin, capecitabine, fluorouracil, tegafur and folinic acid in colorectal cancer (CRC). Primary endpoint: treatment completion rate. Started Feb 2020; status: completed.
02
Drugs
oxaliplatincapecitabinefluorouraciltegafurfolinic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCT1051190106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051190106.